Spero Therapeutics shares fall after $105M KKR deal
Spero Therapeutics, a biotech company, received a big investment from KKR. The company's shares went down after the deal. This deal is worth $105 million.
5.8Significance
1 source6.0Source trust
Spero Therapeutics
Connected entities
Appears in 2 topic(s)
Spero Therapeutics secures $105m financing for drug development
Spero Therapeutics got $105m to make its new medicine. This money will help the company make its drug better and faster.
5.5Significance
1 source5.0Source trust